Chemistry Playbook® is a series of proven, modular, expedited CMC solutions designed to accelerate drug development from carbon to commercialization.
Chemistry Playbook® delivers on speed and quality, but is positioned on program execution.
Cambridge Major Laboratories, Inc., Avantium Pharma, Xcelience, LLC and Beckloff Associates have come together as experts in our respective areas to build a modular program that could achieve the true goal of expedited CMC solutions.
Fixed timelines and price are easy to guarantee under ideal conditions (simple API synthesis, straightforward physical properties, or easy-to-formulate products), but in reality these are rare cases. Recognizing that each drug development candidate is unique, we fit the process to the situation, not the other way around.
Quality can vary across functional business units within larger service providers, but Chemistry Playbook’s consortium model guarantees functional expertise and accountability at every stage.
 | | Play Execution – Gantt charts are situation dependent, maximize flexibility. Project Management bridges functional gaps.
|
| | Bench Strength - Access Beckloff Associates for regulatory oversight, Cambridge Major Laboratories for API, Avantium Pharma for solid state characterization, and Xcelience for formulation development expertise.
|
| | Four Stops, One Shop - Integrated commercial and billing processes provide natural pull and ease of doing business, with CEO level accountability for program success.
|
For more information, please contact:
Brian W. Scanlan
Chief Business Officer, Cambridge Major Laboratories, Inc.
(262) 251-5044 x304
Email
Website
|
Andrei Winkler, MSc, MBA
VP Business Development, NA, Avantium Pharma
(908) 212-4651
Email
Website
|
Derek G. Hennecke
CEO & President, Xcelience, LLC
(813) 286-0404 x112
Email
Website
|
Michael Beckloff
President, Beckloff Associates
(913) 451-3955
Email
Website
|
|
|